ACLX
Arcellx, Inc.
NASDAQ · Healthcare · Biotechnology · US
$115.07
+0.02%Margins
Gross margin
-64.8%
EBITDA margin
-888.3%
EBIT margin
-1135.6%
Net margin
-1027.3%
FCF margin
-953.9%
-56.9%
Return on equity
-37.9%
Return on assets
-50.8%
Return on invested capital
0.04x
Asset turnover
-$210.3M
Cash from operations
$7.70
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025